Global

Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomized superiority trial
Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomized superiority trial 150 150 The Arcady Group

Global Health Work Continues with New Grant Awards
Global Health Work Continues with New Grant Awards 150 150 The Arcady Group

Revolutionizing the TB journey: A patient’s perspective
Revolutionizing the TB journey: A patient’s perspective 666 500 The Arcady Group

Smart Medication Container Included in GDF Product Catalog
Smart Medication Container Included in GDF Product Catalog 565 362 The Arcady Group

Arcady Founder to Speak at The Union Conference
Arcady Founder to Speak at The Union Conference 1200 628 The Arcady Group

TB REACH Digital Adherence Technology Posters
TB REACH Digital Adherence Technology Posters 1080 1080 The Arcady Group

M4ALL Releases Processes to Scale Remdesivir Manufacturing
M4ALL Releases Processes to Scale Remdesivir Manufacturing 2560 1708 The Arcady Group

Results of World Mosquito Program Indonesia Trial
Results of World Mosquito Program Indonesia Trial 2560 1714 The Arcady Group

Arcady’s Founder, Bruce Thomas, served as panelist at AIDS2020
Arcady’s Founder, Bruce Thomas, served as panelist at AIDS2020 1500 1035 The Arcady Group
Accelerating the availability and uptake
of life-saving technologies and medications for patients who need them most.
Meet our leadership.

Navigation

Home
Who We Are
Our Work
New & Resources
Contact Us

Latest Resources

Tuberculosis
Toolkits
Adherence
Innovative Technologies
Special Reports

Stay Connected

©2022 The Arcady Group. All Rights Reserved.

Start Typing
Back to top